Ac Immune Sa
Clinical trials sponsored by Ac Immune Sa, explained in plain language.
-
New shot aims to clear brain plaques in Alzheimer's and down syndrome
Disease control Recruiting nowThis study tests an experimental therapy called ACI-24.060 in people with early Alzheimer's and non-demented adults with Down syndrome. The treatment is designed to train the immune system to attack amyloid plaques in the brain, which are linked to Alzheimer's. The main goals are…
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Healthy volunteers wanted for first human tests of Brain-Targeting drug
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called ACI-19764 in 78 healthy adults aged 18-65. The goal is to check its safety, how the body handles it, and its effects on immune markers. Participants receive either the drug or a placebo, once or daily for 14 days. This study does not…
Phase: PHASE1 • Sponsor: AC Immune SA • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC